Patents by Inventor Stephane Peluso

Stephane Peluso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heteroaryl compounds useful as inhibitors of E1 activating enzymes
    Publication number: 20080051404
    Abstract: This invention relates to compounds that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.
    Type: Application
    Filed: August 6, 2007
    Publication date: February 28, 2008
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Christopher Claiborne, Stephen Critchley, Courtney Cullis, Steven Langston, Hiro Mizutani, Edward Olhava, Stephane Peluso, Irache Visiers, Stepan Vyskocil, Gabriel Weatherhead
  • Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
    Publication number: 20070155705
    Abstract: The present invention relates to heterocyclic compounds that bind to Bcl proteins and inhibit Bcl function, compositions comprising such compounds, and methods for treating and modulating disorders associated with hyperproliferation, such as cancer.
    Type: Application
    Filed: December 15, 2006
    Publication date: July 5, 2007
    Applicant: Infinity Pharmaceuticals, Inc.
    Inventors: Alfredo Castro, Michael Grogan, Edward Holson, Brian Hopkins, Nii Koney, Stephane Peluso, Daniel Snyder
  • Inhibitors of E1 activating enzymes
    Publication number: 20060189636
    Abstract: This invention relates to compounds that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.
    Type: Application
    Filed: February 2, 2006
    Publication date: August 24, 2006
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Stephen Critchley, Thomas Gant, Steven Langston, Edward Olhava, Stephane Peluso